MCK vs XNCR · P/E 20, rev $403.43B vs rev $55.7M
McKesson Corporation (MCK) versus Xencor Inc (XNCR) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Xencor Inc (XNCR) is a biotechnology company listed on US.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported XNCR revenue for 2026-06-30 was $55.7M. Net income was -$150.6M. XNCR currently screens at market cap $664.0M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. XNCR currently screens at market cap $664.0M.
Not investment advice. Open the MCK and XNCR stock pages for the full models.
Not investment advice.